Login / Register
0

RET Breakapart

RET Breakapart

Catalog Number:
ISH1136190CEL
Mfr. No.:
CF1019
Price:
Inquiry
  • Size:
    Quantity:
    Add to Cart:
    Add to Cart
      • Overview

        • Clinic Significance：
          1.This occurs in 1-2% of patients with non-small cell lung adenocarcinoma
          2.The expression was lower in normal lung tissue, and the gene rearrangement activated the kinase active domain of RET, and the expression was higher in lung cancer samples.
          Three targeted drugs, Vandetanib, Sorafenib and Sunitinib, inhibit the activity of multiple receptor tyrosine kinases including RET, and to kill cells carrying RET fusion gene.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          FISH
          Other Properties
          Probe: RET

          * For research use only.

      • Applications
        • Application
          Fluorescent In Situ Hybridization

    We Also Recommend

    HER2 Gene Amplification Detection Kit

    HER2 Gene Amplification Detection Kit

    NTRK1 Breakapart Detection Kit

    NTRK1 Breakapart Detection Kit

    PIK3CA Gene Amplification Detection Kit

    PIK3CA Gene Amplification Detection Kit

    TERT Gene Amplification

    TERT Gene Amplification

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    • Products
    Amerigo Scientific
    Support
    Contact Us
    Copyright © Amerigo Scientific. All rights reserved.